Skip to Content

P13 (Quetiapine Fumarate Extended-Release 400 mg)

Pill with imprint P13 is White, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 400 mg. It is supplied by TruPharma, LLC.

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for P13

Quetiapine Fumarate Extended-Release

Imprint
P13
Strength
400 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
TruPharma, LLC
National Drug Code (NDC)
52817-0164
Inactive Ingredients
ethylcelluloses, microcrystalline cellulose, lactose monohydrate, sodium citrate, silicon dioxide, magnesium stearate, titanium dioxide, magnesium silicate, polyethylene glycol, polyvinyl alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "P13"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.